Faecal microbiota transplantation (FMT) is recognised as an emerging treatment for recurrent Clostridium difficile infections in patients where antibiotic and other lines of treatment have failed.
FMT is outside the scope of the Human Tissue (Quality and Safety for Human Application) Regulations, 2007 (as amended) and is not regulated by the HTA.
Establishments seeking to perform FMT should contact the MHRA Medicines Borderline Section for further advice.
Audience
Display last updated on date
Off
Display anchor links
Off
In this section
None
Exclude from search
No